Long-term Complications, Extraintestinal Manifestations, and Mortality in Adult Crohn's Disease in Population-Based Cohorts

被引:163
|
作者
Peyrin-Biroulet, Laurent [1 ]
Loftus, Edward V., Jr. [1 ]
Colombel, Jean-Frederic [2 ]
Sandborn, William J. [1 ]
机构
[1] Mayo Clin, Div Gastroenterol & Hepatol, Rochester, MN 55905 USA
[2] CHU Lille, Hop Claude Huriez, F-59037 Lille, France
关键词
Crohn's disease; extraintestinal complications; natural history; osteoporosis; thromboembolism; demyelinating disorders; colorectal dysplasia; colorectal cancer; small intestinal cancer; mortality; population-based; INFLAMMATORY-BOWEL-DISEASE; MANITOBA IBD COHORT; OLMSTED COUNTY; ULCERATIVE-COLITIS; INTESTINAL CANCER; INCREASED RISK; BONE-DENSITY; FOLLOW-UP; CORTICOSTEROID USE; COPENHAGEN COUNTY;
D O I
10.1002/ibd.21417
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: Crohn's disease (CD) is a chronic, progressive, destructive disease. Numerous intestinal and extraintestinal complications and manifestations can occur during its clinical course. This literature review summarizes our current knowledge of the long-term complications, extraintestinal complications, and mortality in CD in adults as reported in population-based studies that include long-term follow-up results. Methods: A literature search of English and non-English language publications listed in the electronic databases of Medline (source PubMed, 1935 to July, 2009). Results: The relative risk of incident fractures is increased in CD patients by approximate to 30%-40%. These patients have also have a 3-fold increased risk of deep venous thrombosis and pulmonary embolism. A variety of extraintestinal manifestations (primary sclerosing cholangitis, ankylosing spondylitis, iritis/uveitis, pyoderma gangrenosum, erythema nodosum) and diseases (asthma, bronchitis, pericarditis, psoriasis, rheumatoid arthritis, and multiple sclerosis) are associated with CD. The risks of colorectal and small bowel cancers relative to the general population are 1.4-1.9 and 21.1-27.1, respectively. A slightly increased risk of lymphoma, irrespective of medication use, has been reported in a recent meta-analysis of population-based studies. Overall mortality is slightly increased in CD, with a standardized mortality ratio of 1.4. Conclusions: CD is frequently associated with disease complications and extraintestinal conditions. Whether the impact of changing treatment paradigms with increased use of immunosuppressives and biologic agents can reduce disease complications and associated conditions is unknown.
引用
收藏
页码:471 / 478
页数:8
相关论文
共 50 条
  • [1] Gastrointestinal complications and extraintestinal manifestations of inflammatory bowel disease in Taiwan: A population-based study
    Hsu, Yung-Cheng
    Wu, Tzee-Chung
    Lo, Yu-Cheng
    Wang, Li-Shu
    JOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2017, 80 (02) : 56 - 62
  • [2] The Natural History of Adult Crohn's Disease in Population-Based Cohorts
    Peyrin-Biroulet, Laurent
    Loftus, Edward V., Jr.
    Colombel, Jean-Frederic
    Sandborn, William J.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2010, 105 (02) : 289 - 297
  • [3] Extraintestinal manifestations in Crohn's disease and ulcerative colitis: results from a prospective, population-based European inception cohort
    Isene, Rune
    Bernklev, Tomm
    Hoie, Ole
    Munkholm, Pia
    Tsianos, Epameonondas
    Stockbruegger, Reinhold
    Odes, Selwyn
    Palm, Oyvind
    Smastuen, Milada
    Moum, Bjorn
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2015, 50 (03) : 300 - 305
  • [4] Review of the disease course among adult ulcerative colitis population-based longitudinal cohorts
    Magro, Fernando
    Rodrigues, Andreia
    Vieira, Ana Isabel
    Portela, Francisco
    Cremers, Isabelle
    Cotter, Jose
    Correia, Luis
    Duarte, Maria Antonia
    Tavares, Maria Lourdes
    Lago, Paula
    Ministro, Paula
    Peixe, Paula
    Lopes, Susana
    Garcia, Elizabeth Benito
    INFLAMMATORY BOWEL DISEASES, 2012, 18 (03) : 573 - 583
  • [5] Mortality in ulcerative colitis and Crohn's disease. A population-based study in Finland
    Manninen, Pia
    Karvonen, Anna-Liisa
    Huhtala, Heini
    Rasmussen, Martin
    Salo, Maarit
    Mustaniemi, Leena
    Pirttiniemi, Ismo
    Collin, Pekka
    JOURNAL OF CROHNS & COLITIS, 2012, 6 (05) : 524 - 528
  • [6] The long-term incidence of dysplasia and colorectal cancer in a Crohn's colitis population-based cohort
    Gatenby, Grace
    Glyn, Tamara
    Pearson, John
    Gearry, Richard
    Eglinton, Tim
    COLORECTAL DISEASE, 2021, 23 (09) : 2399 - 2406
  • [7] Long-term outcomes and predictors of disabling disease in a population-based cohort of patients with incident Crohn's disease diagnosed between 1994 and 1997
    Rabilloud, Marie-Laure
    Bajeux, Emma
    Siproudhis, Laurent
    Hamonic, Stephanie
    Pagenault, Mael
    Brochard, Charlene
    Gerfaud, Agathe
    Dabadie, Alain
    Viel, Jean-Francois
    Tron, Isabelle
    Robaszkiewicz, Michel
    Bretagne, Jean-Francois
    Bouguen, Guillaume
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2022, 46 (09)
  • [8] Long-term outcome of pediatric-onset Crohn's disease: A population-based cohort study
    Fumery, Mathurin
    Pariente, Benjamin
    Sarter, Helene
    Savoye, Guillaume
    Spyckerelle, Claire
    Djeddi, Djamal
    Mouterde, Olivier
    Bouguen, Guillaume
    Ley, Delphine
    Peneau, Anais
    Dupas, Jean-Louis
    Turck, Dominique
    Gower-Rousseau, Corinne
    Andre, J. M.
    Antonietti, M.
    Aoukli, A.
    Armand, A.
    Aroichane, I
    Aubet, J. P.
    Auxenfants, E.
    Bankovski, D.
    Barbry, B.
    Bardoux, N.
    Baron, P.
    Baudet, A.
    Bazin, B.
    Bebahani, A.
    Becqwort, J. P.
    Benet, V
    Benali, H.
    Benguigui, C.
    Ben Soussan, E.
    Bental, A.
    Berkelmans, I
    Bernet, J.
    Bernou, K.
    Bernou-Dron, C.
    Bertot, P.
    Biron, N.
    Bismuth, B.
    Bleuet, M.
    Blondel, F.
    BohonF
    Boniface, E.
    Bonniere, P.
    Bonvarlet, E.
    Bonvarlet, P.
    Boruchowicz, A.
    Bostvironnois, R.
    Boualit, M.
    DIGESTIVE AND LIVER DISEASE, 2019, 51 (04) : 496 - 502
  • [9] Adalimumab for Crohn's disease: Long-term sustained benefit in a population-based cohort of 438 patients
    Peters, Charlotte P.
    Eshuis, Emma J.
    Toxopeus, Florien M.
    Hellemons, Merel E.
    Jansen, Jeroen M.
    D'Haens, Geert R. A. M.
    Fockens, Paul
    Stokkers, Pieter C. F.
    Tuynman, Hans A. R. E.
    van Bodegraven, Adriaan A.
    Ponsioen, Cyriel Y.
    JOURNAL OF CROHNS & COLITIS, 2014, 8 (08) : 866 - 875
  • [10] Overall and Cause-Specific Mortality in Crohn's Disease: A Meta-analysis of Population-Based Studies
    Duricova, Dana
    Pedersen, Natalia
    Elkjaer, Margarita
    Gamborg, Michael
    Munkholm, Pia
    Jess, Tine
    INFLAMMATORY BOWEL DISEASES, 2010, 16 (02) : 347 - 353